1.1Shade from an opaque canopy
An aluminum roof intercepts direct sunlight above the workstation. Extended eaves and solid side panels reduce direct exposure from low sun angles and limit the portion of the sky visible from the workstation.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
An aluminum roof intercepts direct sunlight above the workstation. Extended eaves and solid side panels reduce direct exposure from low sun angles and limit the portion of the sky visible from the workstation.
The controller calculates solar elevation from site coordinates and local time. It opens the work window when the sun drops below six degrees beneath the horizon in the evening and closes it when the sun crosses that elevation in the morning.
The formulation distributes acrylic particles and carries the primary ultraviolet filters in the applied layer. As water evaporates, the polymer particles coalesce into a continuous film that limits filter wash-off during immersion.
The applied layer contains trimethylsiloxysilicate dissolved in isododecane. As the carrier evaporates, the resin deposits a water-insoluble film that holds the ultraviolet filters on the skin.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Disperse surface-treated rutile titanium dioxide in a waterborne acrylic textile binder and add an aqueous solution of the mycosporine-like amino acid during mixing. Apply the dispersion to the weather-facing side of woven polyester with a coating knife and dry it to form a continuous finish. Measure UV transmission through the fabric before and after repeated water sprays to quantify retention of UV attenuation.
Replace the particulate mineral UV filter with bemotrizinol and dissolve it in a heated oil phase containing C12–15 alkyl benzoate. Emulsify the oil phase into water with a nonionic emulsifier and mix in the dissolved mycosporine-like amino acid during cool-down. Examine the cooled emulsion for filter crystals under polarized light and measure film UV transmission before and after water immersion.
Apply an emulsion containing a primary UV filter and the mycosporine-like amino acid to roughened acrylic plates at 1.0, 1.5, and 2.0 mg/cm². Condition the coatings for 20 minutes and immerse separate plates from each coat mass group for 20, 40, or 80 minutes at 30 °C. Record spectral transmittance from 290 to 400 nm before and after immersion to compare retained UV attenuation across the nine conditions.
Prepare three oil-in-water emulsions with fixed concentrations of the primary UV filter and mycosporine-like amino acid and with 0%, 1%, or 2% active acrylates copolymer by mass. Add the copolymer as an aqueous dispersion during cool-down and adjust the added water to account for the dispersion mass. Apply equal coating masses to matched plates and compare residual UV attenuation after immersion and probe tack on separate dried films.
Prepare an oil-in-water emulsion with an oil-soluble primary UV filter in the dispersed phase and the mycosporine-like amino acid in the continuous aqueous phase. Fill the emulsion above the follower piston in an airless metering pump and prime the pump until it delivers a complete stroke. The follower piston rises as the pump dispenses, and a gravimetric check tracks the mass delivered per stroke from the first full dose through the end of the fill.
Use a robotic film applicator to spread a formulation containing a primary UV filter and the mycosporine-like amino acid onto roughened acrylic plates. A motorized rack moves the plates between a UV spectrophotometer, a temperature-controlled immersion bath, and a drying station. Software corrects each spectrum using an uncoated plate reference and reports the ratio of post-immersion to pre-immersion integrated absorbance separately for the UVA and UVB bands.
An alkylsilane surface treatment improves wetting of zinc oxide particles in an ester oil. High-shear mixing breaks up agglomerates and distributes the particles, which attenuate UVA and UVB radiation.
Diethylamino hydroxybenzoyl hexyl benzoate dissolves in a liquid ester emollient during preparation of the oil phase. The dissolved filter absorbs UVA radiation in the applied layer.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
The UV-absorbing agents convert the UV energy into heat energy and release it, and include, for example, an organic compound such as 4-tert-butyl-4′-methoxydibenzoylmethane. The UV scattering agents contain an inorganic particle such as titanium oxide (TiO2) and zinc oxide (ZnO), and when the UV scattering agent is applied to the skin, the inorganic particles present on the skin reflect UV rays and serve as a UV barrier.A · US 10,307,356 B2 · ¶ 6
(12) A mycosporine-like amino acid represented by Formula 1:A · US 10,307,356 B2 · ¶ 35
Mycosporine-like amino acids are amino acids having a cyclohexanone structure and known to be produced by algae such as seaweed and microalgae, marine products, and fungi, and other organisms.B · US 2022/0168253 A1 · ¶ 31
An empty cell means only that no passage was reproduced there.
Furthermore, extraction and production from natural products are easily influenced by climate conditions and mostly unstable, and thus, it is difficult to obtain MAAs stably in a large amount.A · US 10,307,356 B2 · ¶ 8
In the meantime, microbial biosyntheses of MAAs have been tried; however, these processes require disruption of cells and extraction with an organic solvent in order to obtain biosynthesized MAAs from the microbial cells (Patent Document 3 and Non-Patent Documents 5 and 6).A · US 10,307,356 B2 · ¶ 8
Since it is unclear whether type I collagen or elastin is absorbed and efficiently reaches the site of action as described above, there is a need of a type I collagen or elastin production promoter for producing type I collagen or elastin by using a highly absorbable natural ingredient.B · US 2022/0168253 A1 · ¶ 7
An object of the present invention is to provide a novel type I collagen or hyaluronic acid production promoter.B · US 2022/0168253 A1 · ¶ 8
patent.fyi, US 2026/0355082 A1, claim 1, first published 2026-11-19T07:53:10-05:00, https://patent.fyi/US20260355082/, SHA-256 b1f75bf44f2cd3eed16923b02e5f4e94c3ff03fbe53011d9559aff7611d78645